Skip to main content
The Technology Co., Ltd. logo

The Technology Co., Ltd. — Investor Relations & Filings

Ticker · 043090 ISIN · KR7043090000 KO Wholesale and retail trade
Filings indexed 597 across all filing types
Latest filing 2022-03-16 Proxy Solicitation & In…
Country KR South Korea
Listing KO 043090

About The Technology Co., Ltd.

https://we-gov.org/

An organization focused on advancing smart and sustainable urban development. It facilitates global collaboration and knowledge exchange through initiatives, workshops, and forums that bring together students, young professionals, and urban leaders. The organization's programs explore the intersection of artificial intelligence, nature-based solutions, and youth-driven urban leadership. It emphasizes the critical role of emerging technologies and collaborative governance in shaping the future of urban environments, with a presence in Europe, North America, and Southeast Asia.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Hanchang Biotech. It outlines the meeting date, location, agenda items (such as approval of financial statements and director remuneration), and provides detailed governance information including board activity and audit committee reports. This type of document is standard for providing shareholders with the necessary information to vote on matters at an upcoming meeting, which falls under the Proxy Solicitation & Information Statement category.
2022-03-16 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Hanchang Biotech. It outlines the date, time, location, and agenda items (such as financial statement approval and director compensation). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2022-03-16 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company scheduled its AGM on a date that coincides with many other companies' meetings, citing audit report receipt and operational constraints. Since this is a specific regulatory disclosure regarding meeting logistics and does not fit into the other categories like AGM-R (presentation materials) or PSI (proxy solicitation), it is best classified as a general regulatory filing.
2022-03-16 Korean
전환가액의조정(제17회차, 제18회차)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Hanchang Biotech) detailing the adjustment of conversion prices for convertible bonds (CB). This type of disclosure, which involves changes to the capital structure and potential future share issuance, falls under the category of 'Capital/Financing Update' (CAP) as it directly relates to the terms of financing instruments.
2022-03-02 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Hanchang Biotech) regarding the adjustment of the conversion price of convertible bonds (CB). This type of filing, which details changes to the terms of existing financial instruments (specifically conversion prices due to market price fluctuations), falls under capital structure changes. In the provided taxonomy, 'CAP' (Capital/Financing Update) is the most appropriate category for updates on financing activities and capital structure changes.
2022-02-03 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Hanchang Biotech) announcing a significant change (over 30%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial changes. Since it provides key financial highlights and performance metrics rather than a full annual report or a simple publication notice, it falls under the category of an Earnings Release (ER) as it serves as the initial announcement of financial results. FY 2021
2022-02-03 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.